Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Daily News Briefs
Aug 2003
Royal Philips Electronics of the Netherlands has established several new research collaborations through its new molecular imaging (MI) business unit, which is in the process of setting up an MI user group and a scientific advisory board. Under a three-year National Cancer Institute contract, Philips is collaborating with Washington University, Dow Chemical and Kereos to develop target-specific nantotechnology molecular agents. The company has also begun a collaborative research project with Washington University and Kereos to develop a targeted contrast agent for computed tomography (CT), and is working with the Theseus Imaging subsidiary of North American Scientific Inc. to optimize the methodology for in vivo imaging of cardiac cell death. Philips showcased its MI technologies at the 2nd annual meeting of the Society for Molecular Imaging (SMI) last week in San Francisco. In June, Phillips introduced MOSAIC, an advanced "small bore" animal positron emission tomography (PET) imaging system. It also announced an exclusive worldwide distribution agreement with ImTek Inc., of Knoxville, Tenn., for ImTek's MicroCAT II in-vivo x-ray CT scanner, also for use in animal research.

Dow ChemicalKereosmolecular imagingnantotechnologyNews BriefsPhotonics Tech BriefsTheseus ImagingWashington University

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.